Settable surgical compositions and methods of use

A first reactive composition and a second reactive composition, the first reactive composition comprising:

• about 38.9 wt % to about 40.9 wt % ALD;
• about 6.2 wt % to about 8.2 wt % tocopherol acetate;
• about 0.01 wt % to about 1.1 wt % calcium stearate;
• about 6.9 wt % to about 8.9 wt % β-TCP powder;
• and
• about 43.8 wt % to about 45.8 wt % HA powder;
• and
• the second reactive composition comprising:
• about 0.1 wt % to about 1.9 wt % ALD;
• about 27.6 wt % to about 29.6 wt % PCL;
• about 0.1 wt % to about 1.9 wt % BDO;
• about 6.9 wt % to about 8.9 wt % TEA;
• about 0.1 wt % to about 1.2 wt % triacetin;
• about 0.9 wt % to about 2.9 wt % calcium stearate;
• and about 58.6 wt % to about 60.6 wt % HA powder.